Remedium Lifecare Ltd - Stock Valuation and Financial Performance

BSE: 539561 | NSE: | Trading | Small Cap

Remedium Lifecare Share Price

1.82 -0.09 -4.71%
as on 28-Mar'25 12:27

DeciZen - make an informed investing decision on Remedium Lifecare

M-Cap below 100cr DeciZen not available

Remedium Lifecare stock performance -

P/E Ratio (SA):
0.00
Market Cap:
73.4 Cr.
52-wk low:
1.8
52-wk high:
31.3

Is Remedium Lifecare Ltd an attractive stock to invest in?

1. Is Remedium Lifecare Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Remedium Lifecare Ltd is a average quality company.

2. Is Remedium Lifecare Ltd undervalued or overvalued?

The key valuation ratios of Remedium Lifecare Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Remedium Lifecare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Remedium Lifecare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Remedium Lifecare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Remedium Lifecare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 24.6%0.7%0.1%0.6%0.6%11.2%7.4%18.2%102.5%99.5%-
Value Creation
Index
0.8-1.0-1.0-1.0-1.0-0.2-0.50.36.36.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.13.91.30.40.22.9905055104,0421,549
Sales YoY Gr.-85.4%-66.2%-73.7%-54.3%1,706.3%3,015.2%460.7%1%692.7%-
Adj EPS 000000000.10.5-1.2
YoY Gr.--100%NANANANA0%200%300%275%-
BVPS (₹) 0.10.10.10.10.10.10.10.10.31.11.2
Adj Net
Profit
0.600000.30.51.14.918-50
Cash Flow from Ops. 0.1-1.40.1-0.2-0.1-0.2-10.211.320.5-74.2-
Debt/CF from Ops. 1.2000-1.1-1.8-100-0.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 131.5%659.4%255.4%692.7%
Adj EPS 52.7%NA255.7%275%
BVPS33.4%68%120.4%311.5%
Share Price - 55.5% 13.6% -93.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
21.40.30.10.50.28.413.324.563.467.7-110.3
Op. Profit
Mgn %
-7.8-7.6-7.40.2-43.213.40.80.41.40.9-2.3
Net Profit
Mgn %
27.70.20.33.93.99.40.50.210.5-3.2
Debt to
Equity
000000.12.7001.3-
Working Cap
Days
8674151,0503,2436,36635182944851391,961
Cash Conv.
Cycle
6633258012,1892,0451101017272143

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 255.41%

Sales growth is good in last 4 quarters at 373.63%

Return on Equity is Poor

Latest Financials - Remedium Lifecare Ltd.

Standalone Consolidated
TTM EPS (₹) -1.2 -
TTM Sales (₹ Cr.) 1,549 -
BVPS (₹.) 1.2 -
Reserves (₹ Cr.) 37 -
P/BV 1.57 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 1.82 / 31.25
All Time Low / High (₹) 0.10 / 44.91
Market Cap (₹ Cr.) 73.4
Equity (₹ Cr.) 40.3
Face Value (₹) 1
Industry PE 56.2

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 1,408 1763.677.7 -76.525.1 -94.738.2 -97.9
Adj EPS (₹) -5.3 N/A0 -69.20 -750 -98.3
Op. Profit Mgn % -2.49 134 bps0.50 -170 bps17.78 1643 bps-14.36 -1734 bps
Net Profit Mgn % -3.81 252 bps2.10 51 bps7.08 569 bps2.00 -50 bps

Management X-Ray of Remedium Lifecare:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:1.11%Institutions:0%Non-Institutions:98.89%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240.0%0.2%0.4%0.6%0.8%1.0%1.2%1.4%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Remedium Lifecare

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Remedium Lifecare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Redington 243.2 -1.4 (-0.6%) Small Cap 41,228 17.8 2.6 13.7 4.4
Amrapali Industries 15.5 -0.3 (-2.1%) Small Cap 27,301 0.1 0 123.7 2.5
Rashi Peripheral 293.1 3.6 (1.2%) Small Cap 10,731 28.3 1.3 10.2 1.1
Prithvi Exchange (I) 150.9 -3.1 (-2%) Small Cap 4,160 13.7 0.3 11.3 2.5
Remedium Lifecare 1.8 -0.1 (-4.7%) Small Cap 4,042 -1.2 0.4 - 1.7
SG Mart 323.3 16.9 (5.5%) Small Cap 2,683 9.4 2.2 32.7 2.9
Manoj Vaibhav Gems 201.1 2.6 (1.3%) Small Cap 2,150 19.3 3.8 10.3 1.4
Sakuma Exports 2.4 -0 (-1.7%) Small Cap 1,874 0.1 0.5 28.9 0.8
Honasa Consumer 232.7 -1.8 (-0.8%) Small Cap 1,764 2.1 6.4 111.9 6.5
Anmol India 14.7 -0.1 (-0.5%) Small Cap 1,501 1.6 1.3 9 0.8
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales2.123.931.330.350.162.8990.03504.79509.844,041.71
Operating Expenses 2.294.231.430.350.232.5089.31502.98502.674,007.51
Manufacturing Costs0.210.590.790.020.010.130.211.741.741.01
Material Costs1.853.390.460.140.051.6787.74498.47493.864,001.38
Employee Cost 0.110.050.040.130.040.180.190.210.550.40
Other Costs 0.110.210.140.060.130.521.172.566.524.72
Operating Profit -0.17-0.30-0.100-0.070.390.721.827.1734.19
Operating Profit Margin (%) -7.9%-7.6%-7.4%0.2%-43.2%13.4%0.8%0.4%1.4%0.8%
Other Income 0.910.330.100.020.090.010.010.010.8321.10
Interest 00.010000.010.020.230.454.78
Depreciation 0.010.010000.010.060.070.150.06
Exceptional Items 0000000000
Profit Before Tax 0.730.0100.020.020.380.651.537.4050.45
Tax 0.140000.010.100.170.451.9717.72
Profit After Tax 0.590.0100.010.010.280.481.085.4332.73
PAT Margin (%) 27.7%0.3%0.3%3.9%5.0%9.6%0.5%0.2%1.1%0.8%
Adjusted EPS (₹)0.00.00.00.00.00.00.00.00.10.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 3.043.043.043.073.083.353.864.9410.3642.96
Share Capital 3.603.603.603.603.603.603.603.603.6010.08
Reserves -0.56-0.56-0.56-0.53-0.52-0.250.261.346.7632.88
Minority Interest0000000000
Debt0.100000.080.3610.500057.70
Long Term Debt0.100000.080.3610.50000
Short Term Debt00000000057.70
Trade Payables2.401.37000.350.3923.77124.5684.22712.29
Others Liabilities 0.290.160.250.060.020.160.4094.261,059.631,134.95
Total Liabilities 5.834.573.293.133.534.2738.53223.761,154.221,947.90

Fixed Assets

Gross Block1.930.210.210.2100.240.290.340.200.22
Accumulated Depreciation0.500.190.190.2000.010.080.150.120.18
Net Fixed Assets1.430.020.010.0100.230.210.190.080.05
CWIP 0000000000
Investments 0000000000
Inventories1.330.83000.200.703.1183.877.32133.23
Trade Receivables1.982.852.172.030.141.5023.6864172.37920.60
Cash Equivalents 0.010.010.160.021.080.930.811.4421.861.52
Others Assets1.080.860.951.072.110.9110.7274.27952.59892.49
Total Assets 5.834.573.293.133.534.2738.53223.761,154.221,947.90

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0.09-1.360.07-0.16-0.07-0.20-10.2111.2820.50-74.16
PBT 0.730.0100.020.010.380.651.537.4050.45
Adjustment -0.08-0.05-0.090-0.090.010.060.180.193.84
Changes in Working Capital -0.55-1.320.15-0.170-0.59-10.8910.0314.89-110.64
Tax Paid 00000.010-0.04-0.45-1.98-17.81
Cash Flow From Investing Activity 0.101.480.090.021.06-0.24-0.04-0.05-0.040.09
Capex 01.41000.02-0.24-0.04-0.05-0.040
Net Investments 0000000000
Others 0.100.070.090.021.0400000.09
Cash Flow From Financing Activity -0.24-0.11000.080.2910.14-10.61-0.0453.74
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -0.24-0.100000.2910.14-10.5000
Interest Paid 0-0.0100000-0.11-0.04-3.87
Dividend Paid 0000000000
Others 00000.08000057.61
Net Cash Flow -0.0500.15-0.141.06-0.15-0.110.6220.42-20.33
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)21.40.360.110.450.268.6213.3324.5170.92122.76
ROCE (%)24.60.660.140.550.6211.167.3918.16102.5499.51
Asset Turnover Ratio0.320.760.340.110.050.744.213.850.742.61
PAT to CFO Conversion(x)0.15-136N/A-16-7-0.71-21.2710.443.78-2.27
Working Capital Days
Receivable Days3832246882,1892,48710351328549
Inventory Days2801000047057831336
Payable Days00001,4268150547736

Remedium Lifecare Ltd Stock News

Remedium Lifecare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Remedium Lifecare on 28-Mar-2025 12:27 is ₹1.82.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2025 12:27 the market cap of Remedium Lifecare stood at ₹73.38.
The latest P/E ratio of Remedium Lifecare as of 28-Mar-2025 12:27 is 0.00.
The latest P/B ratio of Remedium Lifecare as of 28-Mar-2025 12:27 is 1.57.
The 52-week high of Remedium Lifecare is ₹31.25 and the 52-week low is ₹1.82.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Remedium Lifecare is ₹1,549 ( Cr.) .

About Remedium Lifecare Ltd

Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. The company has made a paradigm shift by entering into the manufacturing of intermediates and APIs and be reckoned as a leading contract manufacturer and as a brand owner of advanced intermediates & APIs. The strategic acquisition of the state-of-the-art manufacturing facilities in Hyderabad, was a timely move to forward integrate and diversify into the pharma & healthcare arena. A massive facility with 2 dedicated manufacturing blocks is now ready for large scale manufacture.

The company is engaged into the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Amino isophthalic Acid, Tellurium (IV) Oxide, Grignard Reagent, lodine, Selenium Metal Powder, Trimethyl Sulfoxonium lodide (TMSI).

Business area of the company

The company is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...